Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples

Authors: Steffen Wolfsgruber, José Luis Molinuevo, Michael Wagner, Charlotte E. Teunissen, Lorena Rami, Nina Coll-Padrós, Femke H. Bouwman, Rosalinde E. R. Slot, Linda M. P. Wesselman, Oliver Peters, Katja Luther, Katharina Buerger, Josef Priller, Christoph Laske, Stefan Teipel, Annika Spottke, Michael T. Heneka, Emrah Düzel, Alexander Drzezga, Jens Wiltfang, Sietske A. M. Sikkes, Wiesje M. van der Flier, Frank Jessen, on behalf of the Euro-SCD working group

Source: Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-11 (2019)

Subject Terms: Subjective cognitive decline, Preclinical Alzheimer’s disease, CSF biomarkers, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571, Neurology. Diseases of the nervous system, RC346-429

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s13195-018-0463-y; https://doaj.org/toc/1758-9193

Access URL: https://doaj.org/article/f450f29649c3469587f26bd207f78434